Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Centre Hospitalier Universitaire de Nice
Age
18–any
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
Patients \> or = 18 years
Patients with advanced melanoma stage IIIC (unresectable) or stage IV
Patient not treated or not responding to chemotherapy with chemotherapy session last\> 1 month
Patients who signed informed consent
Patients presenting no socio-economic, psychological, familial or geographical allow proper understanding of the information leaflet of the protocol or the regular monitoring in the department of dermatology
Patients with a life expectancy greater than 3 months
Patients with melanoma measurable by RECIST version 1.1
Patients with venous good for venipuncture
You may not be if
Patients with contraindication for treatment with chemotherapy or V600E BRAF inhibitor or ipilimumab or have conditions concomitant heavy may interfere with the treatment of metastatic melanoma
Pregnant women or nursing
People vulnerable detainees, adults under guardianship or curatorship, minors.
Clareo Health | Study of Circulating Tumor Cells Before and After Treatment in Patients With Metastatic Melanoma
